Lion's Mane Mushroom (Hericium erinaceus) Contains Two Distinct Classes of Neuroactive Compounds — Hericenones from the Fruiting Body and Erinacines from the Mycelium — Both of Which Cross the Blood-Brain Barrier and Stimulate NGF (Nerve Growth Factor) Synthesis in the Brain, with the 2009 Mori RCT Showing +6.4 Points on a Cognitive Dementia Scale vs +0.5 for Placebo in Adults with Mild Cognitive Impairment Over 16 Weeks
Updated: June 2026 · lion's mane mushroom · lion's mane supplement · lion's mane benefits · lion's mane mushroom benefits · lion's mane brain · lion's mane cognitive · lion's mane memory · lion's mane focus · lion's mane anxiety · lion's mane depression · lion's mane nerve · lion's mane nerve regeneration · lion's mane neuropathy · lion's mane NGF · lion's mane nerve growth factor · hericenones · erinacines · hericenones vs erinacines · hericium erinaceus · hericium erinaceus benefits · hericium erinaceus supplement · hericium erinaceus NGF · lion's mane NGF synthesis · NGF lion's mane · nerve growth factor supplement · nerve growth factor brain · NGF neurogenesis · NGF Alzheimer's · NGF dementia · Mori 2009 lion's mane · Mori lion's mane RCT · lion's mane cognitive impairment · lion's mane mild cognitive impairment · lion's mane MCI · lion's mane Phytotherapy Research · lion's mane clinical trial · lion's mane RCT · Saitsu 2019 lion's mane · lion's mane MoCA · lion's mane cognitive score · lion's mane placebo trial · lion's mane stopped benefits disappeared · lion's mane washout · lion's mane amyloid · lion's mane Alzheimer's · lion's mane dementia · lion's mane amyloid beta · hericenones amyloid · lion's mane plaques · lion's mane neurogenesis · lion's mane BDNF · lion's mane hippocampus · lion's mane neuroplasticity · lion's mane TrkA · lion's mane fruiting body · lion's mane mycelium · fruiting body vs mycelium · lion's mane extract vs powder · lion's mane 8:1 extract · lion's mane 10:1 extract · lion's mane dual extract · best lion's mane supplement · lion's mane dose · how much lion's mane · lion's mane 500mg · lion's mane 1000mg · lion's mane dosing guide · when to take lion's mane · lion's mane morning · lion's mane coffee · lion's mane side effects · lion's mane safe · lion's mane immune · lion's mane gut · lion's mane mood
Lion's Mane (Hericium erinaceus) is a culinary and medicinal mushroom native to North America, Europe, and Asia — distinguished by its cascading white spines that resemble a lion's mane. In East Asian traditional medicine, it has been used for centuries for cognitive and digestive support. The modern pharmacological interest in Lion's Mane is unusually well-mechanistically grounded compared to most botanical supplements: researchers identified two chemically distinct families of compounds that stimulate the synthesis of Nerve Growth Factor (NGF) — hericenones (isolated from the fruiting body in 1991 by Kawagishi et al.) and erinacines (isolated from the mycelium in 1994 by the same group). This mechanistic clarity — a supplement that demonstrably increases a key neurotrophic factor — gives Lion's Mane a plausibility foundation that many adaptogens lack.
NGF (nerve growth factor) is a neurotrophin — a protein that promotes the growth, maintenance, differentiation, and survival of neurons, particularly cholinergic neurons in the basal forebrain (the nucleus basalis of Meynert — the primary source of acetylcholine to the cortex, and the region most depleted in Alzheimer's disease). NGF also supports peripheral sensory and sympathetic neurons. Reduced NGF signaling is implicated in the pathophysiology of Alzheimer's disease, diabetic peripheral neuropathy, and aging-related cognitive decline. A compound that safely stimulates NGF synthesis is therefore of legitimate pharmacological and geroscience interest — with the important caveat that most of the mechanistic evidence comes from in vitro and rodent studies, while human RCT evidence, though positive, remains limited in scale.
Hericenones + Erinacines
the two NGF-stimulating compound families — HERICENONES: isolated from the fruiting body (the above-ground "mushroom" part we eat); chemical class: aromatic compounds (aryl esters of fatty alcohols, phenols); specific compounds: hericenones C, D, E, F, G, H; these compounds stimulate NGF mRNA expression in cell culture (PC12 cells, cortical neurons) → downstream TrkA receptor activation → PI3K/Akt and MAPK/ERK survival pathways → neurite outgrowth; ERINACINES: isolated from the mycelium (the underground root-like network); chemical class: cyathane diterpenes; specific compounds: erinacines A through K; erinacines A, B, and C are the most studied; erinacine A is the most potent NGF stimulator — more potent than the hericenones at equivalent concentrations; critically: erinacines have better confirmed CNS penetration than hericenones in rodent studies (they appear in brain tissue after oral administration in mice); erinacine A stimulates NGF in the hippocampus and cerebellum after oral dosing in mice (Kawagishi 1996, 2008); BOTH REQUIRED: the practical implication is that the most complete Lion's Mane supplement should include both fruiting body extract (hericenones) AND mycelium extract (erinacines); a product that only contains fruiting body may lack erinacines; a product that only contains mycelium grain biomass (common in US dietary supplements) may be primarily starch with minimal erinacine content if the mycelium was not extracted at the erinacine-rich stage; KEY MECHANISM POINT: neither hericenones nor erinacines ARE NGF — they stimulate the body's own synthesis of NGF; this is distinct from exogenous NGF administration (which cannot cross the blood-brain barrier due to its large molecular size, 26.5 kDa, and is the subject of drug development efforts); Lion's Mane works with endogenous production pathways rather than replacing them; ADDITIONAL MECHANISMS: β-glucans (present in fruiting body) activate immunomodulatory pathways (Dectin-1 receptor, NF-κB, macrophage activation) — gut immune modulation independent of NGF; some evidence for direct BDNF upregulation (separate from NGF); anti-inflammatory effects via COX inhibition by hericenones
Mori 2009 RCT
the key human evidence: Mori K et al. (2009, Phytotherapy Research): the most cited Lion's Mane human RCT; DESIGN: double-blind, randomized, placebo-controlled trial; N=30 adults with Mild Cognitive Impairment (MCI) — the pre-dementia stage; age: 50–80 years; all participants Japanese; INTERVENTION: Yamabushitake (Lion's Mane fruiting body extract) 250mg tablet × 4 per day = 1,000mg/day total vs matching placebo; duration: 16 weeks; OUTCOME: Hasegawa Dementia Rating Scale (HDS-R) — a validated Japanese cognitive assessment tool similar to MMSE, scored 0–30 (higher is better); RESULTS: Lion's Mane group: HDS-R increased from ~22.0 to ~28.4 (Δ+6.4 points); Placebo group: HDS-R increased from ~22.0 to ~22.5 (Δ+0.5 points); the difference was highly statistically significant (p < 0.001) at weeks 8, 12, and 16; CRITICAL FINDING — WASHOUT REVERSAL: 4 weeks after stopping Lion's Mane, cognitive scores in the treatment group fell back toward baseline (HDS-R returned to ~23.4 from ~28.4); the placebo group showed no change; this is a key data point: (a) it confirms the benefit was due to Lion's Mane (reversible with discontinuation); (b) it implies ongoing supplementation is required to maintain benefit — similar to a medication, not a cure; LIMITATIONS: N=30 is a small trial; the study was not powered for Alzheimer's disease endpoints; participants were Japanese, aged, with MCI — results may not generalize to younger healthy adults; the HDS-R improvement (+6.4) is substantial (a 6-point change corresponds to a meaningful clinically-perceptible improvement in daily cognitive function); REPLICATION: Saitsu 2019 (Biomedical Research, N=31, older adults aged 50–80): Lion's Mane 500mg/day × 8 weeks; MoCA (Montreal Cognitive Assessment) scores improved significantly vs baseline within the Lion's Mane group; no significant placebo-controlled comparison published at the same time point; overall the Mori 2009 data remains the most rigorous human evidence
Amyloid + Neuroprotection
Alzheimer's disease-relevant mechanisms: AMYLOID-β AGGREGATION: the amyloid cascade hypothesis of Alzheimer's disease proposes that misfolded amyloid-β (Aβ) peptides aggregate into plaques → trigger tau hyperphosphorylation → neuroinflammation → neurodegeneration; hericenones (specifically hericenone E) have been shown in vitro to inhibit Aβ peptide aggregation directly (Xu 2014: hericenone E inhibits Aβ42 fibril formation at micromolar concentrations); this is suggestive but requires in vivo and human validation before clinical implications can be drawn; ALZHEIMER'S MOUSE MODELS: Erinacine A in Alzheimer's model mice (5XFAD mice): Tsai 2019 (Journal of Biomedical Science): oral erinacine A supplementation (1.5mg/kg) for 3 months → reduced amyloid plaque burden in hippocampus and cortex; increased NGF levels in the hippocampus; improved performance on water maze (spatial memory); the authors proposed erinacine A reduces Aβ by increasing ADAM10 (α-secretase activity) and decreasing BACE1 (β-secretase activity) — shifting APP processing toward the non-amyloidogenic pathway; NGF AND CHOLINERGIC NEURONS: NGF is the primary survival factor for basal forebrain cholinergic neurons (BFCNs) — the neurons that project to cortex and hippocampus and whose loss underlies the memory impairment of Alzheimer's disease (the "cholinergic hypothesis"); Lion's Mane → NGF → TrkA receptor on BFCNs → survival, maintenance of acetylcholine synthesis → maintained cholinergic transmission; importantly, this mechanism is also why Lion's Mane may help peripheral neuropathy — NGF supports peripheral sensory neurons and their axonal regeneration after injury; PERIPHERAL NERVE REGENERATION: Kolotushkina 2003: mycelium extract promoted neurite outgrowth from peripheral neurons in vitro; case reports and small studies in peripheral diabetic neuropathy show improvements in nerve conduction velocity; no large RCT in peripheral neuropathy yet; INFLAMMATION AND NEUROINFLAMMATION: β-glucans in Lion's Mane modulate microglial activation (the brain's resident immune cells); dual-extract products with high β-glucan content may provide anti-neuroinflammatory effects complementary to the NGF-stimulation pathway
Forms and Quality
the supplement quality problem is severe in Lion's Mane: THE GRAIN-SPAWN PROBLEM: many US dietary supplement products labeled "Lion's Mane mycelium" are produced by growing Lion's Mane mycelium on grains (often oats or rice); when the product is processed into powder, the grain substrate is included because it cannot be completely separated; the result is a product that may be 50–80% grain starch with only 20–50% actual mycelium biomass; these products have low or undetectable erinacine content; manufacturers are not required to disclose grain starch content; HOW TO IDENTIFY QUALITY PRODUCTS: look for: (1) fruiting body extract (not just mycelium powder); (2) stated beta-D-glucan percentage (≥20% for fruiting body; ≥10% for mycelium extract; lower % is a sign of dilution with starch or fillers); (3) standardized extract ratio (4:1, 8:1, or dual extract); (4) Certificate of Analysis (CoA) showing beta-glucan content via the enzymatic assay method (not total polysaccharides — starch counts as polysaccharide too); (5) products explicitly stating "no grain substrate" or "grain-free mycelium"; FORMS COMPARED: DRIED FRUITING BODY POWDER: least concentrated; 1,000–2,000mg/day provides the equivalent of the Mori 2009 dose; contains hericenones but variable erinacine content; FRUITING BODY EXTRACT (4:1, 8:1): more concentrated; 500–1,000mg of an 8:1 extract ≈ 4,000–8,000mg dried fruiting body equivalent; DUAL EXTRACT (fruiting body + mycelium extract): the most complete; provides both hericenones and erinacines; look for products with >25% beta-glucan; HOT WATER EXTRACTION (for polysaccharides/beta-glucans) vs DUAL EXTRACTION (hot water + alcohol, for both water-soluble and fat-soluble hericenones): dual extraction is preferred; hericenones are fat-soluble compounds that require alcohol extraction to be bioavailable from the supplement matrix; DOSE: 500–1,000mg/day of a standardized dual extract with ≥20% beta-glucan; or 1,000–2,000mg/day fruiting body powder
Ready to build the full protocol?
The Longevity Stack ranks 20+ compounds by evidence tier — the full biomarker panel, VO2 max protocol, sleep science, hormone chapter, and three budget-level stacks, built from the same research on this page.
Get the Longevity Stack → $19
Lion's Mane Evidence Summary
| Evidence Domain | Quality | Key Evidence | Magnitude | Caveats |
|---|
| Mild Cognitive Impairment | ⭐⭐⭐⭐ Moderate-Strong | Mori 2009 (N=30); Saitsu 2019 (N=31) | +6.4 pts HDS-R over 16 weeks (Mori 2009) | Small N; Japanese elderly population; reverses after discontinuation |
| NGF synthesis stimulation | ⭐⭐⭐⭐⭐ Robust mechanistic | Multiple in vitro + animal studies; Kawagishi 1991–2008 | Dose-dependent NGF mRNA upregulation | In vitro → human translation requires clinical confirmation |
| Alzheimer's prevention | ⭐⭐ Preclinical only | Tsai 2019 (5XFAD mice: −amyloid plaques) | Significant in animal models | No human Alzheimer's RCTs; mouse models often fail to translate |
| Peripheral nerve regeneration | ⭐⭐ Limited | In vitro + case reports | Variable | No large human RCT for peripheral neuropathy |
| Anxiety / depression | ⭐⭐⭐ Moderate | Nagano 2010 (N=30 women: reduced anxiety/irritability); multiple animal studies | Statistically significant but modest in humans | Mechanism may be via NGF/BDNF in limbic system; needs larger trials |
| Immune modulation | ⭐⭐⭐ Moderate | β-glucan activation of Dectin-1/macrophage pathway | In vitro and animal models consistent | Class effect (shared with all β-glucan-containing mushrooms) |
Lion's Mane Protocol — Dose, Form, Timing, and Stacking
Dosing and form selection: MINIMAL EFFECTIVE DOSE (cognitive support): 500mg/day of a standardized dual extract with ≥20% beta-glucan and declared erinacine content; this is the most common quality product entry point; MORI 2009 EQUIVALENT: 1,000mg/day of fruiting body extract (or 500–750mg of an 8:1 dual extract); for active cognitive decline or MCI, this dose is more appropriate; MAXIMUM STUDIED: 4,000mg/day in safety studies — no serious adverse effects; the limiting factor is cost, not safety; FOR HEALTHY ADULTS (<50 years old): 500–750mg/day of a quality dual extract is sufficient for neuroprotective and NGF-supportive purposes; the evidence for cognitive enhancement in healthy young adults is much weaker than in MCI populations; TIMING: morning dosing is conventional; the compound accumulates over weeks — timing within the day matters less than consistency; some users report alertness/focus effects within 1–2 hours of dosing; WHEN TO EXPECT EFFECTS: the Mori 2009 trial saw statistically significant improvements beginning at week 8; do not expect acute cognitive effects; plan a 8–12 week trial minimum before assessing benefit; SUPPLEMENT FORM RED FLAGS: avoid products labeled "Lion's Mane mycelium" or "mycelium biomass" without specified beta-glucan content or "grain-free" declaration — these are likely grain-starch-diluted products; avoid products listing "polysaccharides" as the active marker (starch is a polysaccharide — the marker should specifically say beta-glucans); STACKING: Lion's Mane combines well with: Bacopa monnieri (Brahmi) — complementary cognitive benefits; phosphatidylserine — neuronal membrane support; creatine monohydrate — brain energy/PCr support (see creatine guide); these combinations are not adversarially studied but have non-overlapping mechanisms; no known negative interactions with standard medications or supplements; DISCONTINUATION: the Mori 2009 washout data strongly implies continued use is required for sustained benefit; if you discontinue, expect effects to diminish over 4–6 weeks; COOKING: whole Lion's Mane mushroom (the actual fresh fungus) is an excellent culinary ingredient — crab-like texture when seared, absorbs flavors well; hericenones are heat-stable (withstand cooking temperatures); regular consumption of the whole mushroom provides lower doses of bioactives than concentrated extracts but adds variety to diet.
Lion's Mane Dual Extract →
Organic Fruiting Body Powder →
As an Amazon Associate, LongevityLab earns from qualifying purchases made through links on this page. This does not affect the price you pay.